New News information at Practical Patient Care

ReadyGo Diagnostics Ltd. Announces its Partnership with Porex for Global Sampler Production

Thu, 18 Apr 2024 11:14:00 GMT

by

ReadyGo Diagnostics initiates volume manufacturing of its sample collection and preparation device with Porex.

The British In Vitro Diagnostics Association (BIVDA) has released new three-year strategy, ‘Diagnostics for All’

Thu, 18 Apr 2024 10:43:00 GMT

by

The British In Vitro Diagnostics Association (BIVDA) have released new three-year strategy, ‘Diagnostics for All’.

P95 Expands Its Global Presence with a New USA Office

Wed, 17 Apr 2024 13:43:00 GMT

by

P95, a leading global provider of clinical and epidemiology services focused on vaccines and infectious diseases, has opened its first office in the USA. Based in the Research Triangle Park in North Carolina, the largest research park in the USA, this expansion underlines P95s commitment to delivering high-quality research solutions to our clients and partners across the globe.

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

Wed, 17 Apr 2024 10:36:00 GMT

by

On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF) in Shanghai. Drawing on the Group's core competence in R&D and its wealth of top-quality raw materials, devices, modules, and system R&D resources, VITAL HealthCare has captured the spotlight with its forward-looking product development plan on this inaugural showcase.

Beckman Coulter’s Dxl 9000 Immunoassay Analyzer Extends Menu With New CE-Marked Hepatitis Assays at ESCMID Global

Wed, 17 Apr 2024 10:36:00 GMT

by

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays. Recently, tests for Hepatitis B and C viruses — namely Access anti-HCV, Access HBsAg, and Access HBsAg Confirmatory assays — received CE marks.

Insightec Announces Exablate Prime Availability In Europe -The next generation Of MR-guided focused ultrasound

Wed, 17 Apr 2024 10:35:00 GMT

by

Insightec reaffirms its position at the forefront of the medical technology industry with improved functionality, safety features, and efficiency to its flagship product, setting new benchmarks in the field with unparalleled achievements.

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

Wed, 17 Apr 2024 10:35:00 GMT

by

The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more than 150 countries. Prominent companies in the industry seized the opportunity to showcase their cutting-edge products and comprehensive solutions, covering every aspect of the industry chain. The exhibition served as a dynamic platform for collaboration, innovation, and exploration, significantly boosting global medical device trade.

CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution

Wed, 17 Apr 2024 10:34:00 GMT

by

CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive technology, which is the first in CSafe's CGT Cryo Series, maintains temperatures colder than -150°C.

WHS Ranks Topical Oxygen Level 1 Evidence

Tue, 16 Apr 2024 12:27:00 GMT

by

Exciting news in the realm of wound care! The Wound Healing Society has recently increased topical oxygen therapy to 'Level 1' evidence in its updated DFU treatment guidelines, signifying a significant leap in the field.

TATAA Biocenter Achieves GLP Accreditation for qPCR and dPCR

Mon, 15 Apr 2024 23:00:00 GMT

by

TATAA Biocenter announced that it has been awarded Good Laboratory Practice (GLP) accreditation. The accreditation represents a crucial step in the company's strategic progression into a market leading molecular analysis contract research organization (CRO) expediting biopharmaceutical innovations in advanced therapies and precision medicine.